STN1013600 ophthalmic solution 0.3%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for STN1013600 ophthalmic solution 0.3%, covering 2024-05-29 to 2024-05-29. Get the full timeline:
Most recent: Clinical Trial Update: Study Assessing the Efficacy and Safety of STN1013600 Ophthalmic Solution 0.1% and 0.3% Compared With Placebo in Subjects With Presbyopia [Phase 2]